CASynergy:一种因果注意模型,用于可解释的癌症药物协同作用的预测

相关实验视频

Updated: Jan 15, 2026

12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.5K

Haitao Li^1,2, Long Zheng^1,2, Lei Li^1,2

¹Key Laboratory of Intelligent Computing & Signal Processing, School of Artificial Intelligence, Anhui University, Hefei, Anhui, China.

PLoS computational biology

|October 15, 2025

概括

预测有效的癌症药物组合对于个性化治疗至关重要. CASynergy是一种新的深度学习模型,通过分析因果基因组特征和细胞系特异性相互作用,准确地识别协同药物对,改进癌症治疗策略.

科学领域:

计算生物学计算生物学
基因组学就是基因组学.
药理学药理学是指药理学的学科.

背景情况:

癌症药物组合疗法看起来很有前途,但由于复杂的生物相互作用和瘤异质性,很难识别协同作用的对.
现有的用于药物协同作用预测的机器学习模型缺乏可解释性,并且难以建模癌症特异性的分子相互作用.

研究的目的:

开发一种新的深度学习模型,CASynergy (因果注意力和交叉注意力协同作用),用于准确和可解释地预测癌症药物协同作用.
解决当前机器学习方法的局限性,包括可解释性差和分子相互作用模型不足.

主要方法:

CASynergy利用因果注意机制来区分真正的因果基因组特征与相关性.
它构建细胞系特定的基因网络,以捕捉独特的癌症分子背景.
一个交叉注意模块将药物分子特征与细胞系基因表达特征集成.

主要成果:

与五个最先进的模型相比,CASynergy在两个基准数据集 (DrugCombDB和瘤屏幕) 上表现出更高的性能.
该模型成功地确定了显著的药物基因相互作用,并为预测的协同作用提供了可解释的见解.
CASynergy 在不同类型的癌症中显示出有效性.

结论:

CASynergy为预测有效的癌症药物组合提供了一种更可靠和可解释的方法.
该模型的可解释性对于个性化癌症治疗和发现新的治疗策略至关重要.
CASynergy正在推进用于瘤学的计算药物发现领域.

相关概念视频

01:21

Cancer Survival Analysis

645

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

645

02:50

Combination Therapies and Personalized Medicine

5.9K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

5.9K

01:27

Combined Effects of Drugs: Synergism

6.7K

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

6.7K

01:28

Structure-Activity Relationships and Drug Design

1.7K

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

1.7K

02:57

Targeted Cancer Therapies

8.6K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

8.6K

02:53

Adaptive Mechanisms in Cancer Cells

6.9K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...